Article
Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.
Diagnostic pathology - 15 Jan 2013
Wang Miao, Zhou Chunju, Cai Rongqin, Li Yong, Gong Liping
Abstract excerpt
BACKGROUND: Amplification of MYCN oncogene is an established marker indicating aggressive tumor progression of neuroblastoma (NBL). But copy number analyses of MYCN gene in ganglioneuroblastoma (GNBL) and ganglioneuroma(GN) is poorly described in the literature. In the study, we evaluated the copy number aberrations of MYCN gene in clinical samples of NBLs, GNBLs and GNs and analyzed their association with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.